Adverse drug reactions

Area of Science:

• Pharmacovigilance
• Clinical Pharmacology
• Patient Safety

Background:

• Adverse drug reactions (ADRs) remain a significant cause of patient injury and morbidity.
• Despite established protocols for drug prescription and administration, ADRs persist as a critical healthcare challenge.
• New pharmaceutical agents introduce novel and often unknown risks that necessitate rigorous post-market surveillance.

Purpose of the Study:

• To highlight the ongoing challenges posed by adverse drug reactions.
• To emphasize the critical need for enhanced monitoring of new drugs.
• To underscore the importance of comprehensive patient history in risk assessment.

Main Methods:

• This study is a review of existing literature and clinical practice guidelines.
• Analysis of reported cases of adverse drug reactions.
• Discussion of risk factors contributing to ADRs.

Main Results:

• Adverse drug reactions continue to cause substantial patient harm, irrespective of prescribing and administration safeguards.
• Inadequate monitoring and selection of high-toxicity drugs exacerbate patient risks.
• Poor patient history-taking practices contribute to the challenge of managing ADRs.

Conclusions:

• Continuous vigilance and improved monitoring systems are essential to minimize patient harm from medications.
• Careful drug selection and thorough patient evaluation are paramount in preventing adverse drug events.
• Addressing these challenges is vital to reduce morbidity and mortality associated with adverse drug reactions.